Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Neoplasms of the CNS

  Free Subscription


30.09.2019

2 Clin Cancer Res
1 J Clin Oncol
4 J Neurooncol
3 J Neurosurg
1 J Nucl Med
1 Neuro Oncol
1 Neurol Res
2 Neurosurgery
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Cancer Res

  1. VAN DER VOORT SR, Incekara F, Wijnenga MM, Kapsas G, et al
    Predicting the 1p/19q co-deletion status of presumed low grade glioma with an externally validated machine learning algorithm.
    Clin Cancer Res. 2019 Sep 23. pii: 1078-0432.CCR-19-1127.
    PubMed     Text format     Abstract available

  2. SHARIFI Z, Abdulkarim B, Meehan B, Rak J, et al
    Antitumor Activity of a Binary EGFR/DNA Targeting Strategy Overcomes Resistance of Glioblastoma Stem cells to Temozolomide.
    Clin Cancer Res. 2019 Sep 20. pii: 1078-0432.CCR-19-0955.
    PubMed     Text format     Abstract available


    J Clin Oncol

  3. HONG AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, et al
    Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.
    J Clin Oncol. 2019 Sep 25:JCO1901414. doi: 10.1200/JCO.19.01414.
    PubMed     Text format     Abstract available


    J Neurooncol

  4. SJOBERG RL, Wu WY, Dahlin AM, Tsavachidis S, et al
    Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study.
    J Neurooncol. 2019 Sep 25. pii: 10.1007/s11060-019-03294.
    PubMed     Text format     Abstract available

  5. RUDA R, Pellerino A, Pace A, Carapella CM, et al
    Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
    J Neurooncol. 2019 Sep 25. pii: 10.1007/s11060-019-03277.
    PubMed     Text format     Abstract available

  6. SCHIMMEL WCM, Gehring K, Hanssens PEJ, Sitskoorn MM, et al
    Cognitive functioning and predictors thereof in patients with 1-10 brain metastases selected for stereotactic radiosurgery.
    J Neurooncol. 2019 Sep 24. pii: 10.1007/s11060-019-03292.
    PubMed     Text format     Abstract available

  7. HOFFMAN DI, Abdullah KG, McCoskey M, Binder ZA, et al
    Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
    J Neurooncol. 2019 Sep 21. pii: 10.1007/s11060-019-03298.
    PubMed     Text format     Abstract available


    J Neurosurg

  8. GESSLER F, Bruder M, Duetzmann S, Tritt S, et al
    Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors.
    J Neurosurg. 2017 Apr 7:1-7. doi: 10.3171/2016.11.JNS161871.
    PubMed     Text format     Abstract available

  9. ESEONU CI, Eguia F, Garcia O, Kaplan PW, et al
    Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy.
    J Neurosurg. 2017 Jun 16:1-7. doi: 10.3171/2017.1.JNS162913.
    PubMed     Text format     Abstract available

  10. WANG Z, Xing B
    Letter to the Editor. Detection of MRI-negative Cushing's disease by FLAIR imaging: is it reliable?
    J Neurosurg. 2018 May 4:1-2. doi: 10.3171/2017.12.JNS173041.
    PubMed     Text format    


    J Nucl Med

  11. DE ZWART PL, van Dijken BR, Holtman GA, Stormezand GN, et al
    Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.
    J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809.
    PubMed     Text format     Abstract available


    Neuro Oncol

  12. VERBURG N, Koopman T, Yaqub MM, Hoekstra OS, et al
    Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Neuro Oncol. 2019 Sep 24. pii: 5573318. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurol Res

  13. ISHIHARA E, Takahashi S, Fukaya R, Ohta S, et al
    Identification of KLRC2 as a candidate marker for brain tumor-initiating cells.
    Neurol Res. 2019 Sep 26:1-7. doi: 10.1080/01616412.2019.1672390.
    PubMed     Text format     Abstract available


    Neurosurgery

  14. AZAD TD, Veeravagu A, Li A, Zhang M, et al
    Long-Term Effectiveness of Gross-Total Resection for Symptomatic Spinal Cord Cavernous Malformations.
    Neurosurgery. 2018 Feb 6. pii: 4841637. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. SUZUKI Y, Nakamura Y, Yamada K, Kurabe S, et al
    Aquaporin Positron Emission Tomography Differentiates Between Grade III and IV Human Astrocytoma.
    Neurosurgery. 2017 Jun 21. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  16. FALTERMEIER C, Chai T, Syed S, Lau N, et al
    Survival of infants </=24 months of age with brain tumors: A population-based study using the SEER database.
    PLoS One. 2019;14:e0223051.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. VALDOR R, Garcia-Bernal D, Riquelme D, Martinez CM, et al
    Glioblastoma ablates pericytes antitumor immune function through aberrant up-regulation of chaperone-mediated autophagy.
    Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1903542116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: